---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-110686"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2023-04-21T23:59:59+00:00"
generated_at: "2026-06-16T21:48:11.356632+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD sets combined 2022/2023 annual meeting for June 19, 2023

## Summary
- Annual meeting set for June 19, 2023; record date April 20, 2023 (past).
- Company did not hold a 2022 annual meeting; 2022 and 2023 meetings combined.
- Deadline for Rule 14a-8 shareholder proposals is May 1, 2023.
- Deadline for director nominations and universal proxy notices also May 1, 2023.

## SEC filing metadata
- accession: 0001193125-23-110686
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2023-04-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312523110686/0001193125-23-110686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312523110686/d473325d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-110686
- JSON: https://secwatch.observer/filing/0001193125-23-110686.json
- Plain text: https://secwatch.observer/filing/0001193125-23-110686.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.